GTS Securities’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-31,400
Closed -$10K 4554
2023
Q4
$10K Sell
31,400
-6,885
-18% -$1.77K ﹤0.01% 3926
2023
Q3
$10.3K Buy
38,285
+9,726
+34% +$3.54K ﹤0.01% 3823
2023
Q2
$14.4K Buy
+28,559
New +$17.1K ﹤0.01% 1153

Other funds holding ASXC

GTS Securities's ASXC Position: Q1 2024 in Review

GTS Securities sold out of Asensus Surgical, Inc. (ASXC) in Q1 2024, closing a stake of 31,400 shares — an estimated $10K sold.

GTS Securities first reported a position in ASXC in Q2 2023 and held it in 3 quarters. The position peaked at $14.4K in Q2 2023. 72 funds tracked by Wall St. Rank hold ASXC as of Q1 2024.

  • GTS Securities reported no remaining Asensus Surgical, Inc. position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 31,400 Asensus Surgical, Inc. shares in Q1 2024, an estimated $10K.
  • GTS Securities first reported a position in Asensus Surgical, Inc. in Q2 2023 and held it in 3 quarters.
  • GTS Securities's Asensus Surgical, Inc. position peaked at $14.4K in Q2 2023.
  • 72 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.